Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The antidiuretic effect of arginine vasopressin (AVP) is mediated by renal-type (V2) receptors linked to adenylyl cyclase. We report here the cloning of the rat kidney V2 AVP receptor complementary DNA that encodes a 370-amino-acid protein with a transmembrane topography characteristic of G protein-coupled receptors, and with similarity to the V1a (hepatic) AVP receptor in its seven membrane-spanning domains. Expression of the cloned cDNA in mammalian cells showed specific ligand binding and activity characteristic of the native V2 AVP receptor. The receptor messenger RNA is detected only in the kidney. The human V2 receptor gene has been localized to the long arm of the X chromosome close to the locus for nephrogenic diabetes insipidus, an X-linked recessive disorder characterized by renal resistance to the antidiuretic action of AVP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,577
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Self-citationExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
Research works printed but not linked: 1
- Holmes, M. C., Antoni, F. A. & Szentendrei, T. Neuroendocrinology 117, 421–423 (1985).
Cited by
Items 301–400 of 523
Rawat, A., Chaube, R., & Joy, K. P. (2015) · Fish Physiology and Biochemistry · doi:10.1007/s10695-015-0026-0 · Cited by 21
“3; Lolait et al. 1992; Hasunuma et al. 2007; Konno et al. 2009, 2010).”
BackgroundInfluentialDiabètes insipides néphrogéniques
Bichet, D. G. (2006) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2006.07.010 · Cited by 22
Vasopressin and sensory circumventricular organs
Jurzak, M., & SCHMID, H. A. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61572-1 · Cited by 20
Anomalous antidiuretic activity of antidiuretic hormone antagonists
Kinter, L. B., Caltabiano, S., & Huffman, W. F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90427-x · Cited by 18
Knepper, M. A., Valtin, H., & Sands, J. M. (2000) · Comprehensive physiology · doi:10.1002/cphy.cp070313 · Cited by 17
Inverse PCR-mediated cloning of the promoter for the rat vasopressin V2 receptor gene
Mandon‐Pepin, B., Bellanger, A.-C., & Elalouf, J. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00373834 · Cited by 19
The biochemical and physiological characteristics of receptors
Feener, E. P., & King, G. L. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00079-3 · Cited by 17
De novo design of heterotrimeric coiled coils
Lombardi, A., Bryson, J. W., & DeGrado, W. F. (1996) · Biopolymers · doi:10.1002/(sici)1097-0282(1996)40:5<495::aid-bip7>3.0.co;2-r · Cited by 48
Arginine vasopressin regulates CFTR and ClC-2 mRNA expression in rat kidney cortex and medulla
Morales, M. M., Nascimento, D., Capella, M. A. M., Lopes, A. G., & Guggino, W. B. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100671 · Cited by 17
“All PCR products were sequenced and the amplified portion showed the same nucleotide sequence found for V1a, V1b, and V2 cDNA of Wistar rats previously published [11, 12 , 19, 20, 29].”
MethodStoev, S., Cheng, L., Olma, A., Kliś, W. A., Manning, M., Sawyer, W. H., Wo, N. C., & Chan, W. Y. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199903)5:3<141::aid-psc180>3.0.co;2-6 · Cited by 19
González, C. B., Herrera, V. L. M., & Ruiz‐Opazo, N. (1997) · Hypertension · doi:10.1161/01.hyp.29.4.957 · Cited by 17
Searcy, B. T., Bradford, C. S., Thompson, R. R., Filtz, T. M., & Moore, F. L. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.09.017 · Cited by 16
Arpin‐Bott, M., Kaissling, B., Waltisperger, E., Rabhi, M., Saussine, P., Freund‐Mercier, M. J., & Stoeckel, M. E. (2002) · Nephron Experimental Nephrology · doi:10.1159/000058346 · Cited by 16
G Protein–Coupled Receptor Signalling in the Kidney
Weiss, R. H. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00137-x · Cited by 16
Sato, K., Fukuno, H., TANIGUCHI, T., SAWADA, S., Fukui, T., & Kinoshita, M. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.808 · Cited by 16
Role of Oxytocin/Vasopressin-Like Peptide and Its Receptor in Vitellogenesis of Mud Crab
Lin, D., Wei, Y., & Ye, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072297 · Cited by 15
Dong, Y., Sheng, H., Chen, X., Yin, J., & Su, Q. (2006) · BMC Genetics · doi:10.1186/1471-2156-7-53 · Cited by 15
“The AVPR2 receptor, which is composed of 371 amino acids, consists of seven transmembrane domains, four extracellular domains and four cytoplasmic domains, and belongs to the superfamily of G protein-coupled receptors (GPCRs) [10-12].”
BackgroundTerashima, Y., Kondo, K., & Oiso, Y. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00078-8 · Cited by 15
WANG, J., Hodges, R. S., & Sykes, B. D. (1995) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1995.tb01063.x · Cited by 15
Klingler, C., Ancellin, N., Barrault, M., Morel, A., & Corman, B. (1998) · Biochemical Journal · doi:10.1042/bj3301023 · Cited by 15
Self-citationVasopressin V1A receptor mediates cell proliferation through GRK2-EGFR-ERK1/2 pathway in A7r5 cells
Zhang, L., Wang, X., Cao, H. W., Chen, Y., Chen, X., Zhao, X. W., Xu, F., Wang, Y., Woo, A. Y., & Zhu, W. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.023 · Cited by 14
Wells, S. E., Flavell, D. M., Bisset, G. W., Houston, P. A., Christian, H., Fairhall, K. M., & Robinson, I. C. A. F. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00323.x · Cited by 14
“Magnocellular VP is involved in the maintenance of homeostatic salt and water balance during dehydration by promoting water reabsorption in the kidney (Lolait et al. 1992).”
BackgroundMouillac, B., & Mendre, C. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_50 · Cited by 15
Everard, M. J., Macaulay, V. M., Millar, J. L., & Smith, I. E. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90019-c · Cited by 14
Pharmacological characterization of YM471, a novel potent vasopressin V1A and V2 receptor antagonist
Tsukada, J., Tahara, A., Tomura, Y., Wada, K., Kusayama, T., Ishii, N., Aoki, M., Yatsu, T., Uchida, W., Taniguchi, N., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01813-7 · Cited by 14
Transcriptional Regulation of a Mesangium-Predominant Gene, Megsin
Inagi, R., Miyata, T., Nangaku, M., Ueyama, H., Takeyama, K., Kato, S., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000033507.32175.fa · Cited by 14
Molecular Evolution of Ligand‐Binding Specificity in the Vasopressin/Oxytocin Receptor Familya
van Kesteren, R. E., & Geraerts, W. P. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10728.x · Cited by 14
Nakamura, H. (2000) · Endocrinology · doi:10.1210/en.141.12.4481 · Cited by 14
Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease
Lebedeva, S. A., Margaryan, A. G., Smolyarchuk, Е. А., Nedorubov, A. A., Materenchuk, M. Y., Tonevitsky, A., & Mutig, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176199 · Cited by 13
Diabètes insipides néphrogéniques
Bichet, D. G., & Zellweger, M. (2004) · Encyclopédie médico-chirurgicale. Néphrologie · doi:10.1016/j.emcnep.2003.11.001 · Cited by 14
Mouillac, B., & Mendre, C. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.10.007 · Cited by 13
“Although understanding of cNDI from molecular and cell biological point of view has largely increased since the cloning of the V2R gene in 1992 [9-11], developing alternative strategies to manage water homeostasis and induce antidiuresis in cNDI patients is still obvious.”
BackgroundNoda, Y. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0878-5 · Cited by 13
“V2 receptor is a 371 amino acid protein with 7 membranespanning domains and couples to heterotrimeric G-proteins [8, 9].”
BackgroundStudent, J. T., Sowers, J. R., & Lockette, W. E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.883365 · Cited by 17
Clerget-Froidevaux, M.-S., Elalouf, J., & Germain, G. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00218-9 · Cited by 16
Hormonal and local regulation of uterine activity during parturition: part I — The oxytocin system
Maggi, M., Baldi, E., & Susini, T. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347771 · Cited by 17
Structure and Sequence of the Mouse V1a and V1b Vasopressin Receptor Genes.
Kikuchi, S., Tanoue, A., Goda, N., Matsuo, N., & Tsujimoto, G. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.81.388 · Cited by 13
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms
Andrés, M., Peña, A., Derick, S., Raufaste, D., Trojnar, J., Wiśniewski, K., Trueba, M., Gal, C. S., & Guillon, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.026 · Cited by 13
Postina, R., Kojro, E., & Fahrenholz, F. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_48 · Cited by 13
Pharmacological characterization of a novel AVP4–9 binding site in rat hippocampus
Nakayama, Y., Takano, Y., Shimohigashi, Y., Tanabe, S., Fujita, T., Kamiya, H., & Tsujimoto, G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01955-7 · Cited by 13
Goncharevskaya, O. A., Ei, S., & IuV, N. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01837415 · Cited by 13
“Vasopressin receptors [ 17 ] and water channels [7, 18] have been recently cloned and characterized.”
BackgroundA novel splicing mutation in the V 2 vasopressin receptor
Kamperis, K., Siggaard, C., Herlin, T., Nathan, E., Hertz, J. M., & Rittig, S. (2000) · Pediatric Nephrology · doi:10.1007/s004670000431 · Cited by 13
Migita, K., Hori, N., Manako, J.-I., Saito, R., Takano, Y., & Kamiya, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00753-8 · Cited by 13
Vasopressin receptors and effects during fetal development
Ervin, M. G., Kullama, L. K., Ross, M. G., Leake, R. D., & Fisher, D. A. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90207-o · Cited by 13
Tahara, A., Tsukada, J., Ishii, N., Tomura, Y., Wada, K., Kusayama, T., Yatsu, T., Uchida, W., & Tanaka, A. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00059-2 · Cited by 13
Ramcharan, E. J., & Matthews, M. R. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00478-5 · Cited by 13
Park, F., Koike, G., & Cowley, A. W. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.5.f906 · Cited by 13
Chapter 27 The vasopressin receptor of corticotroph pituitary cells
René, P., & de Keyzer, Y. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39029-0 · Cited by 15
Induction of Aquaporin-1 mRNA following Cardiopulmonary Bypass and Reperfusion
Tabbutt, S., Nelson, D. P., Tsai, N., Miura, T., Hickey, P. R., Mayer, J. E., & Neufeld, E. J. (1997) · Molecular Medicine · doi:10.1007/bf03401817 · Cited by 12
Toba, K., Ouchi, Y., Liang, J., Akishita, M., & Orimo, H. (1994) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)90002-7 · Cited by 12
Molecular cloning of a human oxytocin receptor
Kimura, T., Azuma, C., Takemura, M., Inoue, T., Kikuchi, T., Kubota, Y., Ogita, K., Saji, F., & Tanizawa, O. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90185-b · Cited by 12
Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor
Hutchins, A., Phillips, P. A., Venter, D. J., Burrell, L. M., & Johnston, C. I. (1995) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(95)00125-z · Cited by 12
Vasopressin and a Nonpeptide Antidiuretic Hormone Receptor Antagonist (OPC-31260)
Burrell, L. M., Phillips, P. A., Stephenson, J. M., Risvanis, J., & Johnston, C. I. (1994) · Blood Pressure · doi:10.3109/08037059409101533 · Cited by 12
Chen, S., Webber, M. J., Vilardaga, J., Khatri, A., Brown, D., Ausiello, D. A., Lin, H. Y.-F., & Bouley, R. (2011) · Endocrinology · doi:10.1210/en.2011-1049 · Cited by 11
Conformational selection of vasopressin upon V 1a receptor binding
Che, K., Muttenthaler, M., & Kurzbach, D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.024 · Cited by 11
“Similarly, Pro7 plays a role in V1aR and V2R selectivity [41].”
BackgroundInfluentialUyeki, T. M., Barry, F. L., Rosenthal, S. M., & Mathias, R. S. (1993) · Pediatric Nephrology · doi:10.1007/bf00852546 · Cited by 11
“This has been supported by the cloning and the localization of the human V2 receptor gene close to the locus for NDI [6].”
BackgroundDisorders of the Posterior Pituitary
Muglia, L. J., & Majzoub, J. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50014-4 · Cited by 13
Mendre, C., Dufour, M. N., Roux, S. L., Seyer, R., Guillou, L., Calas, B., & Guillon, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21027 · Cited by 11
Identification of a Novel V1-type AVP Receptor Based on the Molecular Recognition Theory
Herrera, V. L. M., & Ruiz‐Opazo, N. (2001) · Molecular Medicine · doi:10.1007/bf03401855 · Cited by 10
“Several groups have recently cloned V1-type (7,8) and V2-type (9, 10 ) vasopressin receptors using standard expression cloning–and hybridization/polymerase chain reaction (PCR)–based strategies.”
MethodKolaj, M., & Renaud, L. P. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61575-7 · Cited by 9
Disorders of the posterior pituitary
Muglia, L. J., Srivatsa, A., & Majzoub, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00020-2 · Cited by 11
Dou, D., Chen, L., Di, H., Song, Z.-R., Li, S., Bu, X., Dai, Q., Wang, S., Li, J. X., Zhu, X., et al. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13493 · Cited by 12
Lack of Interaction of Vasopressin with its Antisense Peptides: A Functional and Immunological Study
Jurzak, M., Pavo, I. J., & Fahrenholz, F. (1993) · Journal of Receptor Research · doi:10.3109/10799899309073699 · Cited by 10
Toward peptide receptor ligand drugs: Progress on nonpeptides
Freidinger, R. M. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7147-1_4 · Cited by 10
Li, Q., Tian, D., Cen, J., Duan, L., & Xia, W. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01607-3 · Cited by 9
Mohan, S., Lafferty, R. A., Tanday, N., Flatt, P. R., Moffett, R. C., & Irwin, N. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261608 · Cited by 10
Anti-edematous Effects of Tolvaptan in Experimental Rodent Models
Miyazaki, T., Sakamoto, Y., Yamashita, T., Ohmoto, K., & Fujiki, H. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6355-z · Cited by 10
“AVP receptors have three subtypes, V1a [5, 6], V1b [7, 8], and V2 [9, 10], each with distinct physiological functions.”
BackgroundRubiś, B., Krozowski, Z. S., & Trzeciak, W. H. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.032 · Cited by 10
Autoimmune Central Diabetes Insipidus
Bellastella, A., Bizzarro, A., & Bellis, A. D. (2004) · Informa Healthcare eBooks · doi:10.1201/9780203021941.ch22 · Cited by 9
High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699
Koga, K., Nagai, Y., Hanyu, M., Yoshinaga, M., Chaki, S., Ohtake, N., Ozaki, S., Zhang, M., Suhara, T., & Higuchi, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.188698 · Cited by 9
Molecular Characterization of an Aquaporin−2 Mutation Causing Nephrogenic Diabetes Insipidus
Li, Q., Lu, B., Yang, J. Y., Li, C., Li, Y., Chen, H., Li, N., Duan, L., Gu, F., Zhang, J., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665145 · Cited by 9
Molecular Biology of Peptide and Glycoprotein Hormone Receptors
Poyner, D. R., & Hanley, M. R. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6772-7_9 · Cited by 9
Homology between neurohypophyseal hormone receptors
Wheatley, M., Howl, J., Morel, A., & Davies, A. R. L. (1993) · Biochemical Journal · doi:10.1042/bj2960519 · Cited by 9
Self-citationPathogenesis of Hyponatremia: The Role of Arginine Vasopressin
Ishikawa, S., & Schrier, R. W. (2005) · doi:10.1002/9780470987476.ch25 · Cited by 9
Familial Juvenile Gouty Nephropathy: Exclusion of 16p12 from the Candidate Locus
Ohno, I., Ichida, K., Okabe, H., Moritani, M., Itakura, M., Saito, M., Kamatani, N., & Hosoya, T. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000064114 · Cited by 9
“many of the affected members of our family showed nephrogenic diabetes insipidus (NDI). Because congenital NDI generally caused by vasopressin V2 receptor gene abnormality is inherited as an X-linked recessive fashion [”
BackgroundArakawa, H., & Higuchi, Y. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104597 · Cited by 8
Vasopressin receptors V1aand V2 are not osmosensors
Lykke, K., Assentoft, M., Fenton, R. A., ROSENKILDE, M. M., & MacAulay, N. (2015) · Physiological Reports · doi:10.14814/phy2.12519 · Cited by 7
“The V2R has a more restricted distribution, and is predominantly expressed in the kidney (Lolait et al. 1992).”
BackgroundVasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Bichet, D. G., Bouvier, M., Chini, B., Gimpl, G., Guillon, G., Kimura, T., Knepper, M. A., Lolait, S. J., Manning, M., Mouillac, B., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f66/2019.4 · Cited by 9
Self-citationChen, M., Hsiao, Y.-C., Chang, C., Pan, S.-F., Peng, C., Li, Y.-T., Liu, C., Liou, J.-W., & Hsu, H. (2021) · Biomedicines · doi:10.3390/biomedicines9030301 · Cited by 8
“The V279 is located at TM6 and is highly conserved among mammalian AVPR2 receptors, indicating its importance for AVPR2 function [7,37,43].”
BackgroundRouillé, Y., Ouédraogo, Y., Chauvet, J., & Acher, R. (1995) · Neuropeptides · doi:10.1016/0143-4179(95)90039-x · Cited by 8
Hendy, G. N., & Bichet, D. G. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80570-2 · Cited by 8
Schoots, O., Hernando, F., Knoers, N. V. A. M., & Burbach, J. P. H. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-49421-8_6 · Cited by 8
Processing and Ligand-Induced Modifications of the V2 Vasopressin Receptor
Hamid, M., Innamorati, G., Esqueda, E. E., & Birnbaumer, M. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_43 · Cited by 8
Expression cloning of the human V2 vasopressin receptor
Barberis, C., Seibold, A. M., Ishido, M., Rosenthal, W., & Birnbaumer, M. E. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90183-9 · Cited by 8
Molecular characterization of nephrogenic diabetes insipidus
Knoers, N. V. A. M. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)92525-n · Cited by 8
Role of Vasopressin in Central Cardiovascular Regulation
Berecek, K. H. (1992) · Central Neural Mechanisms in Cardiovascular Regulation · doi:10.1007/978-1-4684-9184-5_1 · Cited by 8
Receptor Transduction Pathways Mediating Hormone Action
Kublaoui, B. M., & Levine, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00003-8 · Cited by 7
Mohan, S., Flatt, P. R., Irwin, N., & Moffett, R. C. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14462 · Cited by 7
Evaluation oflixivaptanin euvolemic and hypervolemic hyponatremia and heart failure treatment
Zmily, H. D., Alani, A., & Ghali, J. K. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.783566 · Cited by 7
“The benzoyl chloride acylating agent was prepared from methyl 4-amino-2-chlorobenzoate via amidation with 5-fluoro-2-methylbenzoyl chloride, followed by hydrolysis of the methyl ester and conversion to the acid chloride derivative with thionyl chloride [3].”
BackgroundMethodInfluentialBöckenhauer, D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04883-5.50038-6 · Cited by 7
Nephrogenic Diabetes Insipidus
Brown, D., & Ausiello, D. A. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_69 · Cited by 7
Meyerhof, W., Darlison, M. G., & Richter, D. (1993) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60366-x · Cited by 7
Koukoulas, I., Webb, G. C., Bottema, C. D. K., Gill, C. A., Johnston, C. I., & Aldred, G. P. (1999) · Gene · doi:10.1016/s0378-1119(99)00407-2 · Cited by 7
Up-regulation of vasopressin V1a receptor mRNA in rat facial motoneurons following axotomy
Chritin, M., Roquette, P., Schulz, M. F., Breton, C., & Tribollet, E. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00148-5 · Cited by 7
Davies, K. (1992) · Nature · doi:10.1038/359434a0 · Cited by 7
Nephrogenic Diabetes Insipidus and Vasopressin Receptor Mutations
Bichet, D. G. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1802-9_10 · Cited by 7
Molecular Biology and Gene Regulation of Vasopressin
Tiwari, S., & ECELBARGER, C. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00017-x · Cited by 6
Tolvaptan for the Treatment of Hyponatremia and Congestive Heart Failure
Orlandi, C., Zimmer, C. A., & Gheorghiade, M. (2006) · Future Cardiology · doi:10.2217/14796678.2.6.627 · Cited by 6
“Two receptors have been isolated: the V1 receptor (further divided into V1a [1,2] and V1b [3,4]), localized in the vasculature, the uterus and the brain; and the V2 receptor [5,6], primarily localized in the collecting duct of the renal nephron where it mediates changes in water permeability.”
BackgroundSynthesis and pharmacological profile of non-peptide vasopressin antagonists
Galanski, M. E., Erker, T., Studenik, C. R., Kamyar, M.-R., Rawnduzi, P., Pabstova, M., & Lemmens‐Gruber, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.12.008 · Cited by 6
Congenital nephrogenic diabetes insipidus with marked hyponatremia
Onozaki, A., Suzuki, H., Imamura, N., Katoh, T., & Watanabe, T. (2001) · Clinical and Experimental Nephrology · doi:10.1007/s10157-001-8024-1 · Cited by 6
“Among the disorders of renal insensitivity to arginine vasopressin (AVP) that are classified as nephrogenic diabetes insipidus (DI), some of the congenital disorders are caused by frame-shift due to point mutation of the AVP V2 receptor gene.(1,2) Acquired or transient nephrogenic DI is sometimes caused by hypercalcem…”
BackgroundThe Mutual Regulation of Arginine-Vasopressin and PTHrP Secretion in Dissociated Supraoptic Neurons
Yamamoto, S., Morimoto, I., Tanaka, Y., Yanagihara, N., & Eto, S. (2002) · Endocrinology · doi:10.1210/en.143.4.1521 · Cited by 6
Metadata
- Authors
- Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J.
- Affiliations
- National Institute of Mental Health (US)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1992-05
- Volume
- 357
- Issue
- 6376
- Pages
- 336-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2131706912
- Cited by
- 524
- References
- 27
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 15 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 10 · 2013: 16 · 2012: 8
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- V2 receptor, vasopressin, nephrogenic diabetes insipidus, G protein-coupled receptors, adenylate cyclase, antidiuretic effect, kidney, receptor cloning, cDNA expression, X chromosome, X-linked recessive disorder, receptor mRNA expression
- MeSH terms
- Adenylyl Cyclases, Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Cloning, Molecular, Diabetes Insipidus, DNA, Humans, Kidney, Genetic Linkage, Molecular Sequence Data, Receptors, Angiotensin, Translocation, Genetic, X Chromosome, Restriction Mapping, Gene Expression, Polymerase Chain Reaction, Receptors, Vasopressin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.